Terms: = Liver cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Treatment
19 results:
1. pim Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
Julson JR; Quinn CH; Butey S; Erwin MH; Marayati R; Nazam N; Stewart JE; Beierle EA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203596
[TBL] [Abstract] [Full Text] [Related]
2. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating pim-1.
Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/pim3 axis.
Song W; Shi C
Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic Efficacy of Combined JAK1/2, Pan-pim, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.
Rampal RK; Pinzon-Ortiz M; Somasundara AVH; Durham B; Koche R; Spitzer B; Mowla S; Krishnan A; Li B; An W; Derkach A; Devlin S; Rong X; Longmire T; Eisman SE; Cordner K; Whitfield JT; Vanasse G; Cao ZA; Levine RL
Clin Cancer Res; 2021 Jun; 27(12):3456-3468. PubMed ID: 33782031
[TBL] [Abstract] [Full Text] [Related]
5. pim447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma.
Wadhwani N; Markert HR; Marayati R; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Beierle EA
J Pediatr Surg; 2021 Jun; 56(6):1157-1164. PubMed ID: 33762119
[TBL] [Abstract] [Full Text] [Related]
6. pim kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Anderson JC; Willey CD; Beierle EA
Sci Rep; 2021 Mar; 11(1):5984. PubMed ID: 33727604
[TBL] [Abstract] [Full Text] [Related]
7. pim2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway.
Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY
Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749
[TBL] [Abstract] [Full Text] [Related]
8. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing pim-1.
Qi Y; Yao X; Du X
IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
[TBL] [Abstract] [Full Text] [Related]
9. Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214.
Huang PS; Lin YH; Chi HC; Chen PY; Huang YH; Yeh CT; Wang CS; Lin KH
Sci Rep; 2017 Nov; 7(1):14868. PubMed ID: 29093516
[TBL] [Abstract] [Full Text] [Related]
10. miRNA-370 acts as a tumor suppressor via the downregulation of pim1 in hepatocellular carcinoma.
Pan XP; Wang HX; Tong DM; Li Y; Huang LH; Wang C
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1254-1263. PubMed ID: 28387905
[TBL] [Abstract] [Full Text] [Related]
11. Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects.
Guo Q; Lan P; Yu X; Han Q; Zhang J; Tian Z; Zhang C
Mol Cancer Ther; 2014 Jun; 13(6):1503-13. PubMed ID: 24723452
[TBL] [Abstract] [Full Text] [Related]
12. T-18, a stemonamide synthetic intermediate inhibits pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug.
Wang Z; Li XM; Shang K; Zhang P; Wang CF; Xin YH; Zhou L; Li YY
Oncol Rep; 2013 Mar; 29(3):1245-51. PubMed ID: 23314349
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a phenanthrene derivative as a potent anticancer drug with pim kinase inhibitory activity.
Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
[TBL] [Abstract] [Full Text] [Related]
14. Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results.
Louis C; Dewas S; Mirabel X; Lacornerie T; Adenis A; Bonodeau F; Lartigau E
Technol Cancer Res Treat; 2010 Oct; 9(5):479-87. PubMed ID: 20815419
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract] [Full Text] [Related]
16. Accelerated hepatocellular carcinoma development in mice expressing the pim-3 transgene selectively in the liver.
Wu Y; Wang YY; Nakamoto Y; Li YY; Baba T; Kaneko S; Fujii C; Mukaida N
Oncogene; 2010 Apr; 29(15):2228-37. PubMed ID: 20101231
[TBL] [Abstract] [Full Text] [Related]
17. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract] [Full Text] [Related]
18. pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.
Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N
Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649
[TBL] [Abstract] [Full Text] [Related]
19. Percutaneous mitoxantrone injection for primary and secondary liver tumors: preliminary results.
Farrés MT; de Baere T; Lagrange C; Ramirez L; Rougier P; Munck JN; Roche A
Cardiovasc Intervent Radiol; 1998; 21(5):399-403. PubMed ID: 9853146
[TBL] [Abstract] [Full Text] [Related]